Patent Assignment
Reel/Frame 074845/0068
Change of Name
Recorded: 2026-06-04
Pages: 7
Assignor
GALAPAGOS
Executed: 2026-05-18
Assignee
LAKEFRONT BIOTHERAPEUTICS
SCHALIËNHOEVEDREEF 20T, MECHELEN, 2800, BELGIUM
Covered Properties
(37)
Solid Forms of (5S)-Cyclopropyl-5-[3-[(3S)-4-(3,5-Difluorophenyl)-3-Methyl-Piperazin-1-Yl]-3-Oxo-Propyl]Imidazolidine-2,4-Dione
Application:
18/267,395 →
Publication:
US 2024/0124424
Treatment of Inflammatory Diseases
Application:
18/578,604 →
Publication:
US 2024/0325404
Pharmaceutical Compositions and Solid Forms of Compound 1 with Fumarate for the Treatment of Inflammatory Disorders
Application:
19/148,644 →
Imidazo[4,5-B]Pyridine Derivatives Useful for the Treatment of Allergic Diseases, Inflammatory Diseases, Metabolic Diseases, Autoinflammatory Diseases, Autoimmune Diseases and Proliferative Diseases
Application:
19/148,652 →
Methods and Means for Treatment of Osteoarthritis
Methods and Means for Treatment of Osteoarthritis
Triazolopyridine Kinase Inhibitors Useful for the Treatment of Degenerative and Inflammatory Diseases
Novel Compound Useful for the Treatment of Degenerative and Inflammatory Diseases
Novel Compound Useful for the Treatment of Degenerative and Inflammatory Diseases
Novel Compound Useful for the Treatment of Degenerative and Inflammatory Diseases
Novel Dihydropyrimidinoisoquinolinones and Pharmaceutical Compositions Thereof for the Treatment of Inflammatory Disorders.
Novel Dihydropyrimidinoisoquinolinones and Pharmaceutical Compositions Thereof for the Treatment of Inflammatory Disorders.
Novel Dihydropyrimidinoisoquinolinones and Pharmaceutical Compositions Thereof for the Treatment of Inflammatory Disorders.
Novel Dihydropyrimidinoisoquinolinones and Pharmaceutical Compositions Thereof for the Treatment of Inflammatory Disorders.
Methods for Identifying Compounds That Inhibit G Protein-Coupled Receptor (GPR84) Agonist-Stimulated Chemotaxis
Novel Compound Useful for the Treatment of Degenerative and Inflammatory Diseases
Novel Compound Useful for the Treatement of Degenerative and Inflammatory Diseases
Novel Compound Useful for the Treatment of Degenerative and Inflammatory Diseases
Novel Compounds and Pharmaceutical Compositions Thereof for the Treatment of Inflammatory Disorders
Novel Compounds and Pharmaceutical Compositions Thereof for the Treatment of Inflammatory Disorders
Novel Compounds and Pharmaceutical Compositions Thereof for the Treatment of Inflammatory Disorders
Novel Compounds and Pharmaceutical Compositions Thereof for the Treatment of Inflammatory Disorders
Novel Compounds and Pharmaceutical Compositions Thereof for the Treatment of Inflammatory Disorders
Novel Compounds and Pharmaceutical Compositions Thereof for the Treatment of Inflammatory Disorders
Molecular Targets and Compounds, and Methods to Identify the Same, Useful in the Treatment of Fibrotic Diseases
5-[(Piperazin-1-Yl)-3-Oxo-Propyl]-Imidazolidine-2,4-Dione Derivatives as Adamts Inhibitors for the Treatment of Osteoarthritis
5-[(Piperazin-1-Yl)-3-Oxo-Propyl]-Imidazolidine-2,4-Dione Derivatives as Adamts Inhibitors for the Treatment of Osteoarthritis
5-[(Piperazin-1-Yl)-3-Oxo-Propyl]-Imidazolidine-2,4-Dione Derivatives as Adamts Inhibitors for the Treatment of Osteoarthritis
5-[(Piperazin-1-Yl)-3-Oxo-Propyl]-Imidazolidine-2,4-Dione Derivatives as Adamts Inhibitors for the Treatment of Osteoarthritis
Novel Compounds and Pharmaceutical Compositions Thereof for the Treatment of Inflammatory Disorders
Novel Compounds and Pharmaceutical Compositions Thereof for the Treatment of Inflammatory Disorders
Novel Dihydropyridoisoquinolinones and Pharmaceutical Compositions Thereof for the Treatment of Inflammatory Disorders
5-[3-[Piperazin-1-Yl]-3-Oxo-Propyl]-Imidazolidine-2,4-Dione Derivatives as Adamts 4 and 5 Inhibitors for Treating E.G. Osteoarthritis
5-[3-[Piperazin-1-Yl]-3-Oxo-Propyl]-Imidazolidine-2,4-Dione Derivatives as Adamts 4 and 5 Inhibitors for Treating E.G. Osteoarthritis
Compounds and Pharmaceutical Compositions Thereof for the Treatment of Inflammatory Disorders
Novel Compounds and Pharmaceutical Compositions Thereof for the Treatment of Inflammatory Disorders
Methods for the Treatment of Polycystic Kidney Disease
Related Assignments
(25)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Oct 15, 2009
From: MENET, CHRISTEL JEANNE MARIE; BLANC, JAVIER
To: GALAPAGOS NV
Reel/Frame 023383/0179 →
Assignment of Assignor's Interest
Sep 13, 2010
From: MENET, CHRISTEL JEANNE MARIE; BLANC, JAVIER
To: GALAPAGOS NV
Reel/Frame 024977/0138 →
Assignment of Assignor's Interest
Nov 7, 2011
From: MILLE-BAKER, BLANDINE; TESSARI, MICHELA ANGELA
To: BIOFOCUS DPI B. V.
Reel/Frame 027297/0838 →
Assignment of Assignor's Interest
Nov 7, 2011
From: BRYS, REGINALD CHRISTOPHE XAVIER; NELLES, LUC; VANDEGHINSTE, NICK ERNEST RENE
To: GALAPAGOS N.V.
Reel/Frame 027297/0841 →
Assignment of Assignor's Interest
Dec 15, 2011
From: BIOFOCUS DPI B.V.
To: GALAPAGOS NV
Reel/Frame 027392/0579 →
Assignment of Assignor's Interest
May 31, 2012
From: MENET, CHRISTEL JEANNE MARIE; HODGES, ALASTAIR JAMES; VATER, HUW DAVID; BIOFOCUS DPI LTD.
To: GALAPAGOS NV
Reel/Frame 028293/0508 →
Assignment of Assignor's Interest
Jul 12, 2012
From: MENET, CHRISTEL JEANNE MARIE; BLANC, JAVIER
To: GALAPAGOS NV
Reel/Frame 028615/0672 →
Assignment of Assignor's Interest
Feb 26, 2013
From: LABEGUERE, FREDERIC GILBERT; NEWSOME, GREGORY JOHN ROBERT; ALVEY, LUKE JONATHAN; SANIERE, LAURENT RAYMOND MAURICE
To: GALAPAGOS NV
Reel/Frame 029879/0541 →
Assignment of Assignor's Interest
Oct 30, 2013
From: HODGES, ALASTAIR JAMES; VATER, HUW DAVID
To: B IOFOCUS DPI LTD.
Reel/Frame 031506/0941 →
Assignment of Assignor's Interest
Oct 30, 2013
From: BIOFOCUS DPI LTD.
To: GALAPAGOS NV
Reel/Frame 031507/0034 →
Assignment of Assignor's Interest
Oct 30, 2013
From: MENET, CHRISTEL JEANNE MARIE
To: GALAPAGOS NV
Reel/Frame 031506/0586 →
Assignment of Assignor's Interest
Jan 6, 2014
From: LABÉGUÈRE, FRÉDÉRIC GILBERT; NEWSOME, GREGORY JOHN ROBERT; ALVEY, LUKE JONATHAN; SANIÈRE, LAURENT RAYMOND MAURICE
To: GALAPAGOS NV
Reel/Frame 031898/0548 →
Assignment of Assignor's Interest
Aug 18, 2014
From: MENET, CHRISTEL JEANNE MARIE; HODGES, ALASTAIR JAMES; VATER, HUW DAVID
To: GALAPAGOS NV
Reel/Frame 033551/0727 →
Assignment of Assignor's Interest
Sep 11, 2014
From: MENET, CHRISTEL JEANNE MARIE; BLANC, JAVIER
To: GALAPAGOS NV
Reel/Frame 033717/0176 →
Assignment of Assignor's Interest
Dec 17, 2014
From: BRYS, REGINALD CHRISTOPHE XAVIER; DESROY, NICOLAS; HECKMANN, BERTRAND; JONCOUR, AGNES MARIE
To: GALAPAGOS NV
Reel/Frame 034526/0229 →
Assignment of Assignor's Interest
Dec 29, 2014
From: BRYS, REGINALD CHRISTOPHE XAVIER; DUPONT, SONIA; GALAPAGOS SASU
To: GALAPAGOS NV
Reel/Frame 034591/0301 →
Assignment of Assignor's Interest
Dec 14, 2015
From: LABÉGUÈRE, FRÉDÉRIC GILBERT; NEWSOME, GREGORY JOHN ROBERT; ALVEY, LUKE JONATHAN; SANIÈRE, LAURENT RAYMOND MAURICE
To: GALAPAGOS NV
Reel/Frame 037285/0156 →
Assignment of Assignor's Interest
Feb 11, 2016
From: MILLE-BAKER, BLANDINE; TESSARI, MICHELA ANGELA
To: BIOFOCUS DPI B.V.
Reel/Frame 037709/0799 →
Assignment of Assignor's Interest
Feb 11, 2016
From: BRYS, REGINALD CHRISTOPHE XAVIER; NELLES, LUC; VANDEGHINSTE, NICK ERNEST RENE
To: GALAPAGOS NV
Reel/Frame 037709/0984 →
Assignment of Assignor's Interest
Feb 11, 2016
From: BIOFOCUS DPI B.V.
To: GALAPAGOS NV
Reel/Frame 037710/0383 →
Assignment of Assignor's Interest
Jul 17, 2017
From: MENET, CHRISTEL JEANNE MARIE; HODGES, ALASTAIR JAMES; VATER, HUW DAVID; BIOFOCUS DPI LTD.
To: GALAPAGOS NV
Reel/Frame 043020/0673 →
Assignment of Assignor's Interest
May 4, 2018
From: LABÉGUÈRE, FRÉDÉRIC GILBERT; NEWSOME, GREGORY JOHN ROBERT; ALVEY, LUKE JONATHAN; SANIÈRE, LAURENT RAYMOND MAURICE
To: GALAPAGOS NV
Reel/Frame 045718/0656 →
Security Interest
Aug 23, 2019
From: GALAPAGOS NV
To: GILEAD SCIENCES, INC.
Reel/Frame 050149/0161 →
Release of Security Interest
Feb 15, 2022
From: GILEAD SCIENCES, INC.
To: GALAPAGOS NV
Reel/Frame 059020/0871 →
Assignment of Assignor's Interest
Jun 15, 2023
From: GALAPAGOS BV
To: GALAPAGOS NV
Reel/Frame 063963/0968 →